world cancer report - iarc
world cancer report - iarc
world cancer report - iarc
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ing the optic tract, brain stem and spinal<br />
cord. It infiltrates adjacent brain structures<br />
but grows slowly and usually has a<br />
favourable prognosis with five-year survival<br />
rates of more than 85% (WHO Grade<br />
I). Some pilocytic astrocytomas occur in<br />
the setting of neurofibromatosis type 1<br />
(NF1), particularly those of the optic nerve<br />
(optic glioma). Other astrocytomas usually<br />
develop in the cerebral hemispheres of<br />
adults and diffusely infiltrate adjacent<br />
brain structures.<br />
Low grade diffuse astrocytomas (WHO<br />
grade II) occur in young adults and grow<br />
slowly. However, they diffusely infiltrate<br />
the brain and cannot, therefore, be completely<br />
surgically resected.<br />
Morphologically, tumour cells resemble<br />
differentiated astrocytes. Mutations in<br />
p53 are found in two-thirds of cases and<br />
are considered an early event. The fiveyear<br />
survival rate is more than 60%.<br />
Anaplastic astrocytomas (WHO grade III)<br />
often develop from low-grade astrocytomas,<br />
grow relatively fast and typically<br />
progress to glioblastoma within two to<br />
three years, accompanied by genetic alterations,<br />
including loss of heterozygosity<br />
(LOH) on chromosome 19.<br />
Glioblastomas (WHO grade IV)<br />
This is the most frequent and most malignant<br />
nervous system tumour. Secondary<br />
glioblastomas develop by malignant progression<br />
from low-grade and anaplastic<br />
astrocytoma and are characterized by p53<br />
mutations and LOH on chromosome 10q.<br />
Primary glioblastomas are more frequent<br />
(>80% of cases) and develop rapidly in the<br />
elderly (mean age, 55 years), with a short<br />
clinical history of less than three months.<br />
Their genetic profile includes amplification<br />
and overexpression of the EGF receptor<br />
gene, PTEN mutations, p16 INK4A deletions<br />
and loss of chromosome 10. Both glioblastoma<br />
types diffusely infiltrate the brain,<br />
including the opposite hemisphere and<br />
show high cellularity and large areas of<br />
necrosis despite excessive vascular proliferation.<br />
Oligodendrogliomas<br />
These neoplasms develop from myelinproducing<br />
oligodendroglial cells or their<br />
Fig. 5.151 An MRI scan of a primary glioblastoma in a 79 year-old patient. A small cortical lesion rapidly<br />
developed into a full-blown glioblastoma with perifocal oedema and central necrosis.<br />
precursors and are typically found in the<br />
cerebral hemispheres of adults, often<br />
including the basal ganglia. Histologically,<br />
they are isomorphic, with a typical honeycomb<br />
pattern and delicate tumour vessels<br />
(“chicken wire” pattern). Anaplastic<br />
oligodendrogliomas (WHO Grade III) show<br />
features of anaplasia and high mitotic<br />
activity and carry a less favourable prog-<br />
nosis. Genetic hallmarks of oligodendrogliomas<br />
are LOH on chromosomes 1p<br />
and 19q. Oligodendrogliomas that carry<br />
these genetic alterations show a remarkable<br />
sensitivity to chemotherapy.<br />
Ependymomas<br />
These gliomas develop from the ependymal<br />
lining of the cerebral ventricles and<br />
Differentiated astrocytes or precursor cells<br />
mutation (>65%)<br />
α<br />
overexpression ( ~ 60%)<br />
Low grade astrocytoma<br />
( ~ 50%)<br />
alteration ( ~ 25%)<br />
Anaplastic astrocytoma<br />
mutation (5%)<br />
loss of expression ( ~ 50%)<br />
α amplification (